Searched for
OSTEOARTHRITIS
Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...- Social media is abuzz with weight-loss drug retatrutide and longevity goals. What is the drug all about?A new weight-loss drug, retatrutide, is generating excitement. This investigational medicine targets three hormone receptors, offering a po...
- Varun Dhawan opens up about daughter's diagnosis. What is DDH and what parents should knowActor Varun Dhawan and his wife Natasha Dalal's daughter, Lara, was diagnosed with Developmental Dysplasia of the Hip (DDH) shortly after b...
- Study reveals a simple technique to ease knee arthritis pain, and it can be as effective as medication: What is gait retraining?A new study in The Lancet Rheumatology suggests gait retraining — making subtle changes to walking patterns — can ease knee osteoarthritis ...
- Arthritis pain relief without drugs or surgery, study suggestsArthritis, a disorder affecting nearly one in four adults over 40, remains a resulting source of constant pain and disability. Osteoarthrit...
- Yoga vs Strengthening exercises: Which is better for knee osteoarthritis? Study reveals surprising resultsA recent study indicates yoga is as effective as strengthening exercises for managing knee osteoarthritis, offering improvements in pain, q...
- Sun Pharma-Moebius Medical anti-osteoarthritis pain drug gets USFDA fast track statusSun Pharma and Moebius Medical have received fast track designation from the USFDA for their non-opioid therapy MM-II, aimed at treating os...
- Sun Pharma-Moebius Medical anti-osteoarthritis injection shows sustained pain relief in clinical trialsSun Pharma and Moebius Medical announced that their intra-articular injection MM-II showed greater pain relief than placebo for up to 26 we...
- World Arthritis Day 2023: Types of arthritis, symptoms, treatment and self-care tipsWorld Arthritis Day observed on October 12 each year, aims to raise awareness of rheumatic and musculoskeletal diseases (RMDs). This year's...
- Around 1 bn people globally will live with osteoarthritis by 2050, says Lancet studyA recent study published in The Lancet Rheumatology journal predicts that nearly one billion people worldwide will be living with osteoarth...
- One billion people globally to have osteoarthritis by 2050: Lancet StudyBy 2050, nearly one billion people globally are projected to be living with osteoarthritis, according to a study published in The Lancet Rh...
- IIT-Guwahati develops framework to assess Knee Osteoarthritis severityResearchers from the Indian Institute of Technology Guwahati have developed an artificial intelligence-based model named OsteoHRNet, which ...
- Pain relievers may worsen arthritis inflammation, study finds"To date, no curative therapy has been approved to cure or reduce the progression of knee osteoarthritis," said the study's lead author, Jo...
- Great news for osteoarthritis patients! New study says walking can ward off knee painPeople who walked for just 10 mins had less structural damage to their knees.
- Scientists develop model for better diagnosis, treatment of osteoarthritisThe paper builds on another recent study the RIT-Cornell team published in Soft Matter that looked at how cartilage's properties resisted f...
- Lupin launches generic drug in the US marketThe Mumbai-based drug firm's product is the generic equivalent of Zyla Life Sciences' Vivlodex Capsules (5 mg and 10 mg). The capsules are ...
- Sun Pharma, Moebius Medical to develop osteoarthritis pain productMM-II is an intra-articular bio lubricant injection which is being developed to provide symptomatic relief of mild-to-moderate osteoarthrit...
- Paracetamol useless in relieving low back painThe study on paracetamol found that there was never a systematic review of the evidence for the drug's usage to treat low back pain.
- Pfizer files patent suit against Lupin, 5 other pharma firmsUS-based pharma giant Pfizer Inc today said it has filed suit against six firms, including India's Lupin, over patent infringement of celec...
- Wockhardt to market arthritis drug with Italian companyPharmaceutical company Wockhardt on Wednesday said it has entered into an agreement with Italy-based Gnosis SpA to market a process-patente...
Load More
